This document provides epidemiological data and an overview of primary and secondary care services for general liver disease in the South West of England and also assesses the main preventable causes, which includes hepatitis C.
Resources
Medical professional
Around 216,000 people in the UK are living with hepatitis C so it is important that all medical professionals have access to the latest training, information and advice on hepatitis C management. Find here links to relevant materials for clinicians, nurses, GPs, prison healthcare staff and other medical professionals.
Showing 31 to 40 of 221 resources
-
Liver Disease in the South West: A health needs assessment
UK, England, South West Aug 2016 Reports & Research PDF -
Laboratory reports of hepatitis C: 2016
This report from Public Health England provides statistics on the number of hepatitis A and hepatitis C laboratory reports in England and Wales from January - March 2016.England, Wales Aug 2016 Reports & Research PDF -
Extrahepatic manifestations of chronic hepatitis C infection
This research article provides an overview of the extrahepatic (i.e. non-liver) impact of hepatitis C, which include cardiovascular, renal, metabolic and central nervous system diseases.UK, Rest of World Aug 2016 Reports & Research PDF -
Hepatitis C in the UK 2016 report
This report, published by Public Health England, summarises the scale of the hepatitis C issue in the UK in 2015, in order to help support focused action in UK countries via their national action plans, and in order to eliminate hepatitis C as a major public health threat by 2030. It provides a host of relevant statistics and information related to prevalence, diagnosis, testing and treatment.UK Aug 2016 Reports & Research PDF -
Hepatitis C among drug users in Europe: Epidemiology, treatment and prevention
This report, produced by the European Monitoring Centre for Drugs and Drug Addiction, provides an overview of the epidemiology of hepatitis C in Europe. It contains chapters on issues such as providing hepatitis C treatment to people who inject drugs, strategies to improve hepatitis C care and increasing uptake of treatment among people who inject drugs, and hepatitis C prevention among people who inject drugs.UK, Rest of World Aug 2016 Reports & Research, Strategy & Planning PDF -
HCV Action good practice case study: Outreach service in Newcastle
This HCV Action good practice case study looks at an outreach service that has been developed in Newcastle. Based at Freeman Hospital, Newcastle, the service delivers three outreach centres in locations across the north east region. Prior to the outreach service, hospital attendance at new hepatitis C patient appointments was less than 50%. The service has resulted in attendance rates of 75%, an increase in the numbers of people being treated, and comparable Sustainable Virological Response (SVR) rates as hospital-based treatment.North East, UK, England Jul 2016 Case study PDF -
Summary report: Hepatitis C good practice roadshow, Newcastle
This report provides a summary of the good practice hepatitis C roadshow held by HCV Action and Public Health England in Newcastle on 17th May 2016. The roadshow was aimed at sharing good practice around hepatitis C and instigating local action to address the virus. The report includes summaries of the talks and workshops held on the day, as well as suggested next steps to be taken in order to tackle hepatitis C more effectively in Newcastle and the wider north east area.North East, UK, England Jun 2016 Reports & Research PDF -
HCV Action and PHE hepatitis C roadshow in Newcastle: Presentations
On 17th May 2016, HCV Action and Public Health England (PHE) staged a hepatitis C good practice roadshow in Newcastle. The event was designed to showcase and share best practice in the prevention, diagnosis, testing and treatment of hepatitis C, and identify specific issues and potential solutions for tackling hepatitis C in Newcastle and the wider north east region.North East, UK, England Jun 2016 Other, Strategy & Planning PDF -
WHO Guidelines for the screening, care and treatment of persons with chronic hepatitis C infection
These guidelines, developed by the World Health Organisation, promote the transition to newer, more effective medicines that have the potential to cure most persons living with hepatitis C infection. They also provide guidance on which specific regimens should be used based on a patient’s clinical history as well as genotype, and are intended to promote the scale-up of hepatitis C treatment.UK, Rest of World Apr 2016 Other, Strategy & Planning PDF -
New treatments for hepatitis C virus (HCV): scope for preventing liver disease and HCV transmission in England
This article provides analysis of the estimated impact of new treatment for hepatitis C on both the prevention of transmission of the virus, and on preventing hepatitis C-related liver disease.
It concludes that focusing treatment solely on people with cirrhosis is not a tenable long-term strategy if continued reductions in new cases of end stage liver disease and hepatocellular carcinoma, as well as reductions in transmission are to be achieved. It also finds that treatment of other groups will need to follow quickly if these reductions are to be achieved.England Apr 2016 Reports & Research PDF